Treatment with HNK (a SIRT3 activator) similarly relieved the cognitive deficits and neuronal apoptosis induced by MS, while 3-TYP (a SIRT3 inhibitor) induced neuronal apoptosis and cognitive deficits in control and NAM-treated adult MS rats. The gene discussed is SIRT3; the disease is Cognitive impairment.